References

Dulai PS, Boland BS, Singh S, et al. Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's Disease. Gastroenterology. 2018;155(3):687-695.e10. doi:10.1053/j.gastro.2018.05.039
Dulai PS, Amiot A, Peyrin-Biroulet L, et al. A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's disease . Aliment Pharmacol Ther. 2020;51(5):553-564. doi:10.1111/apt.15609
ENTYVIO® (vedolizumab) Abbreviated Prescribing Information (EU-MAR2024 – HK-MAY2024).